The new formulation of volatile anesthetic and its application method for mitigating inflammation

The new formulation of volatile anesthetic and its application method for mitigating inflammation

  • CN 102,458,557 B
  • Filed: 05/05/2010
  • Issued: 11/27/2018
  • Est. Priority Date: 05/05/2009
  • Status: Active Grant
First Claim
Patent Images

1. pharmaceutically acceptable composition comprising effectively accelerate the construct of the metered amount of the amount of the healing of wound, whereinThe construct is selected from:

  • (a) volatile anesthetic of dissolution in aqueous solution, wherein the solution further includes effectively mitigating the volatile anestheticAt least one extractant of volatile amount of agent, wherein the solution is the component of emulsion;

    With(b) volatile anesthetic of dissolution in the solution, wherein the solution further includes effectively mitigating the volatile anestheticVolatile amount at least one extractant, wherein the construct further includes solubilizer;

    Wherein the composition further includes pharmaceutically acceptable excipient,Wherein at least one extractant is selected from dimethyl sulfoxide (DMSO), n-methyl-2-pyrrolidone (NMP), diformazanBase formamide, dimethyl acetamide, Isosorbide dimethyl ether, ethyl alcohol, propyl alcohol, PEG-400, PEG-300, diethylene glycol monoethyl ether andIsopropanol,Wherein administration is local or oral,Wherein the volatile anesthetic is selected from Isoflurane, fluothane, enflurane, Sevoflurane, desflurane, methoxyflurane and its mixingObject,Wherein the composition further includes antibiotic.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×